Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma.

@article{Zhong2019EllagicAS,
  title={Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma.},
  author={Chen Zhong and Shuang Qiu and Jialiang Li and Jingling Shen and Yuangang Zu and Jinming Shi and Guangchao Sui},
  journal={Phytomedicine : international journal of phytotherapy and phytopharmacology},
  year={2019},
  volume={59},
  pages={
          152921
        }
}
BACKGROUND Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with poor prognosis. Various chemotherapeutics are used in treatment of HCC, but most of them have significant toxicity to patients. Thus, it is urgently needed to develop new therapeutic strategies to achieve high specificity and tolerable adverse effects. As a natural polyphenol, ellagic acid (EA) demonstrates inhibitory effects in cancers. PURPOSE The goal of the present study to investigate the anticancer… CONTINUE READING
1
Twitter Mention